Are Basic Materials Stocks Lagging Perimeter Solutions, SA (PRM) This Year? — Negative
PRM Zacks Investment Research — November 28, 2025Here is how Perimeter Solutions, SA (PRM) and Fortuna Mining (FSM) have performed compared to their sector so far this year.
Are Finance Stocks Lagging Credicorp (BAP) This Year? — Negative
BAP Zacks Investment Research — November 28, 2025Here is how Credicorp (BAP) and The Bank of New York Mellon Corporation (BK) have performed compared to their sector so far this year.
Are Investors Undervaluing CNA Financial (CNA) Right Now? — Positive
CNA Zacks Investment Research — November 28, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Expeditors International of Washington (EXPD) Stock Outpacing Its Transportation Peers This Year? — Positive
EXPD Zacks Investment Research — November 28, 2025Here is how Expeditors International (EXPD) and LATAM (LTM) have performed compared to their sector so far this year.
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
SKYE GlobeNewsWire — November 28, 2025LOS ANGELES, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Skye Bioscience, Inc. (“Skye” or “the Company”) (NASDAQ: SKYE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 4, 2024 and October 3, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 16, 2026.
Nutanix (NASDAQ: NTNX) fell more than 18% after reporting earnings below analyst expectations and issuing a weak forward outlook. But while the market reacted sharply to the results, the structure of this decline was already in motion.
Nvidia Stock Falls to End Rough Month. Why History Says December Will Be a Relief. — Neutral
NVDA Barrons — November 28, 2025The AI chip maker has had a November to forget. Why December could be better.
Google drops EU antitrust complaint against Microsoft over cloud computing practices — Positive
GOOG GOOGL MSFT Proactive Investors — November 28, 2025Alphabet Inc (NASDAQ:GOOG)'s Google has withdrawn its antitrust complaint against Microsoft Corp (NASDAQ:MSFT) over the company's cloud computing practices in the European Union, following the launch of a broader EU investigation into the sector. The complaint, originally filed by Google in 2024, alleged that Microsoft engaged in anti-competitive licensing practices that locked customers into its Azure cloud platform.
After Plunging 24.4% in 4 Weeks, Here's Why the Trend Might Reverse for Grand Canyon Education (LOPE) — Negative
LOPE Zacks Investment Research — November 28, 2025The heavy selling pressure might have exhausted for Grand Canyon Education (LOPE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Bridgewater's Greg Jensen echoes Michael Burry on Nvidia's AI chips — and says they could help make themselves obsolete — Negative
NVDA Business Insider — November 28, 2025Michael Burry has warned AI giants are overstating how long their Nvidia chips will stay relevant. Bridgewater's Greg Jensen said the chips may be used to invent better chips that make them obsolete.
Can Primoris Sustain Renewables Momentum Amid Shifting Award Timing? — Positive
PRIM Zacks Investment Research — November 28, 2025PRIM navigates shifting timelines as rapid renewables execution boosts revenues but tightens backlog, testing momentum.
Workday Q3 Earnings Beat on Strength in Subscription Services — Positive
WDAY Zacks Investment Research — November 28, 2025WDAY posts strong Q3 results as subscription revenues jump and AI-fueled demand drives broad customer growth.
Is e.l.f. Beauty (ELF) a Buy as Wall Street Analysts Look Optimistic? — Neutral
ELF Zacks Investment Research — November 28, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Earnings Growth & Price Strength Make Goldman Sachs (GS) a Stock to Watch — Positive
GS Zacks Investment Research — November 28, 2025Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? — Positive
BSX Zacks Investment Research — November 28, 2025When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Earnings Growth & Price Strength Make JPMorgan Chase & Co. (JPM) a Stock to Watch — Positive
JPM Zacks Investment Research — November 28, 2025Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Wall Street Analysts See Core & Main (CNM) as a Buy: Should You Invest? — Neutral
CNM Zacks Investment Research — November 28, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Earnings Growth & Price Strength Make Virtu Financial (VIRT) a Stock to Watch — Positive
VIRT Zacks Investment Research — November 28, 2025Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It? — Positive
VKTX Zacks Investment Research — November 28, 2025When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Is Nu (NU) a Buy as Wall Street Analysts Look Optimistic? — Neutral
NU Zacks Investment Research — November 28, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.